| Literature DB >> 35832198 |
Zuhdi O Elifranji1, Bassem Haddad1, Anas Salameh1, Shehadeh Alzubaidi1, Noor Yousef1, Mohammad Al Nawaiseh1, Ahmad Alkhatib2, Razan Aburumman2, Abdulrahman M Karam2, Muayad I Azzam2, Mohammad A Alshrouf2.
Abstract
Background: The distribution of postoperative orthopedic infection and their susceptibility pattern to antibiotics vary regionally and change over time. The incidence of methicillin-resistant Staphylococcus aureus infection is rising worldwide. Therefore, knowledge of the frequency of the causative microorganisms and their susceptibility to antibiotics are necessary for an improved therapeutic outcome. This study aims to study the frequency and distribution of postoperative orthopedic infection and their resistance pattern to antibiotics.Entities:
Year: 2022 PMID: 35832198 PMCID: PMC9273459 DOI: 10.1155/2022/7648014
Source DB: PubMed Journal: Adv Orthop ISSN: 2090-3464
Figure 1Management protocol in patients with suspicion of postoperative infection.
Characteristics of cases with postoperative infection.
| Characteristics |
|
|---|---|
|
| |
| ≤18 | 32 (20.3) |
| 19–40 | 48 (30.4) |
| 41–60 | 28 (17.7) |
| >61 | 50 (31.6) |
|
| |
|
| |
| Male | 100 (63.3) |
| Female | 58 (36.7) |
|
| |
|
| |
| JUH | 110 (69.6) |
| Outside JUH | 48 (30.4) |
|
| |
|
| |
| Trauma | 84 (53.2) |
| Elective | 69 (43.7) |
| Emergency | 5 (3.2) |
|
| |
|
| |
| Hypertension | 42 (26.6) |
| Diabetes mellitus | 38 (24.1) |
| Ischemic heart disease | 11 (7) |
| Chronic kidney disease | 7 (4.4) |
| Thyroid disease | 3 (1.9) |
| None | 103 (65.2) |
JUH, Jordan University Hospital; the symbol a indicates that the sum is greater than 100% because some patients had more than one disease.
Frequency of bacteria in infected patients.
| Microorganisms |
| Age (years ± SD) | Sex (male %) | Postoperative infection (JUH) | Postoperative infection (referred) |
|---|---|---|---|---|---|
|
| |||||
| | 64 (38.1) | 35.5 ± 23.6 | 60.9 | 48 (28.6) | 16 (9.5) |
| Coagulase-negative staphylococci | 40 (23.8) | 51.7 ± 23.6 | 70 | 21 (12.5) | 19 (11.3) |
| | 10 (6) | 59.7 ± 22.7 | 80 | 7 (4.2) | 3 (1.8) |
| | 1 (0.6) | 80.0 ± 0.0 | 100 | 1 (0.6) | 0 |
| Diphtheroid bacilli | 1 (0.6) | 73.0 ± 0.0 | 0 | 0 | 1 (0.6) |
| | 1 (0.6) | 70.0 ± 0.0 | 0 | 0 | 1 (0.6) |
| Actinomyces odontolyticus | 1 (0.6) | 14.0 ± 0.0 | 100 | 0 | 1 (0.6) |
|
| |||||
|
| |||||
| | 14 (8.3) | 49.6 ± 23.1 | 64.3 | 12 (7.2) | 2 (1.2) |
| | 10 (6) | 64.7 ± 19.1 | 40 | 7 (4.2) | 3 (1.8) |
| | 10 (6) | 30.6 ± 20.7 | 70 | 7 (4.2) | 3 (1.8) |
| | 5 (3) | 45.0 ± 22.0 | 60 | 4 (2.4) | 1 (0.6) |
| Acinetobacter species | 5 (3) | 54.8 ± 26.8 | 60 | 3 (1.8) | 2 (1.2) |
| Alcaligenes species | 2 (1.2) | 25.0 ± 0.0 | 0 | 2 (1.2) | 0 |
| Citrobacter species | 2 (1.2) | 45.0 ± 22.6 | 100 | 1 (0.6) | 1 (0.6) |
| Burkholderia species | 1 (0.6) | 25.0 ± 0.0 | 100 | 1 (0.6) | 0 |
| Comamonas testosteroni | 1 (0.6) | 64.0 ± 0.0 | 0 | 0 | 1 (0.6) |
JUH, Jordan University Hospital; data were calculated based on 168 identified bacteria (in 9 cases more than one pathogen was found).
Resistance pattern of gram-positive bacteria to antibiotic agents.
| Antibiotics |
| CoNS |
| Diphtheroid bacilli |
|
|---|---|---|---|---|---|
|
|
|
|
|
| |
| Ampicillin | 36 (91.7) | 28 (85.7) | 8 (37.5) | 1 (0) | 1 (0) |
| Levofloxacin | 61 (9.8) | 40 (45) | 8 (75) | 1 (100) | 1 (0) |
| Gentamicin | 61 (8.2) | 39 (33.3) | 7 (71.4) | 1 (0) | 1 (0) |
| Ciprofloxacin | 32 (12.5) | 11 (45.5) | 4 (100) | — | — |
| Vancomycin | 62 (1.6) | 40 (0) | 8 (0) | 1 (0) | 1 (0) |
| Oxacillin | 62 (77.4) | 40 (87.5) | — | 1 (100) | 1 (100) |
| Erythromycin | 63 (41.3) | 40 (55) | 8 (75) | 1 (100) | 1 (100) |
| Clindamycin | 62 (29) | 40 (30) | 1 (100) | 1 (100) | 1 (100) |
| Linezolid | 26 (0) | 11 (0) | 5 (20) | — | — |
| Tigecycline | 53 (1.9) | 36 (8.3) | 6 (16.7) | 1 (0) | 1 (0) |
| Co-trimoxazole | 31 (25.8) | 11 (18.2) | 1 (0) | — | — |
| Nitrofurantoin | 19 (0) | 8 (0) | 4 (0) | — | — |
| Benzylpenicillin | 32 (96.9) | 11 (100) | 4 (50) | — | — |
| Moxifloxacin | 30 (6.7) | 11 (18.2) | 1 (100) | — | — |
| Tetracycline | 31 (25.8) | 10 (20) | 4 (100) | — | — |
| Chloramphenicol | 34 (2.9) | 30 (13.3) | 7 (14.3) | 1 (0) | 1 (100) |
| Quinupristin | 9 (0) | 1 (0) | 1 (100) | — | — |
| Amoxicillin/clavulanic acid | 2 (100) | — | 1 (0) | — | — |
Data are represented in n (%); data were calculated based on 168 identified bacteria (in 9 cases more than one pathogen was found); CoNS, coagulase-negative Staphylococci; spp., species.
Resistance pattern of gram-negative bacteria to antibiotic agents.
| Antibiotics |
|
|
|
|
|
|---|---|---|---|---|---|
|
|
|
|
|
| |
| Ampicillin | 5 (100) | 4 (100) | — | — | — |
| Levofloxacin | 5 (60) | 4 (25) | 1 (100) | 3 (66.7) | 1 (100) |
| Gentamicin | 14 (50) | 10 (30) | 9 (0) | 5 (20) | 5 (60) |
| Ceftriaxone | 14 (64.3) | 10 (50) | — | 5 (60) | 5 (60) |
| Cefoxitin | 9 (44.4) | 6 (66.7) | — | 3 (100) | — |
| Amikacin | 14 (21.4) | 10 (0) | 10 (20) | 5 (0) | 4 (50) |
| Ciprofloxacin | 14 (42.9) | 10 (60) | 10 (20) | 5 (40) | 4 (75) |
| Cefazolin | 4 (100) | 4 (50) | — | 3 (100) | 1 (100) |
| Imipenem | 14 (35.7) | 10 (0) | 10 (30) | 5 (0) | 5 (80) |
| Ertapenem | 14 (35.7) | 10 (0) | — | 5 (20) | 4 (75) |
| Ceftazidime | 14 (64.3) | 10 (50) | 10 (30) | 5 (60) | 5 (100) |
| Tigecycline | 13 (15.4) | 8 (0) | 1 (0) | 4 (0) | 5 (40) |
| Cefepime | 13 (53.8) | 9 (66.7) | 10 (70) | 5 (40) | 5 (100) |
| Cefotaxime | 9 (44.4) | 6 (33.3) | — | 2 (50) | 4 (75) |
| Co-trimoxazole | 5 (80) | 4 (75) | 2 (100) | 3 (33.3) | 1 (0) |
| Nitrofurantoin | 3 (66.7) | 1 (0) | — | 1 (100) | — |
| Meropenem | 1 (0) | — | 9 (55.6) | 1 (0) | 4 (100) |
| Piperacillin/tazobactam | 5 (60) | 2 (0) | 9 (33.3) | 3 (0) | 4 (100) |
| Colistin sulfate | 1 (0) | — | 2 (0) | — | 4 (0) |
| Minocycline | — | — | 2 (100) | — | 1 (0) |
| Piperacillin | — | — | 4 (50) | — | 1 (100) |
| Ticarcillin/clavulanic acid | — | — | 4 (50) | — | 1 (100) |
| Tobramycin | — | — | 4 (0) | — | 1 (0) |
| Ticarcillin | — | — | 3 (33.3) | — | 1 (100) |
| Aztreonam | 1 (100) | — | 6 (50) | 1 (0) | 3 (66.7) |
| Cefoxitin | 5 (60) | 4 (50) | 1 (100) | 2 (100) | 4 (100) |
Data are represented in n (%); data were calculated based on 168 identified bacteria (in 9 cases more than one pathogen was found); spp., species.
Comparison between the resistance pattern according to the source of infection for the most common bacteria.
| Antibiotics |
| CoNS |
| |||
|---|---|---|---|---|---|---|
| JUH | Referred | JUH | Referred | JUH | Referred | |
| Ampicillin | 23 (87) | 13 (100) | 14 (100) | 14 (71.4) | 5 (20) | 3 (66.7) |
| Levofloxacin | 45 (6.7) | 16 (18.8) | 21 (38.1) | 19 (52.6) | 5 (80) | 3 (66.7) |
| Gentamicin | 46 (6.5) | 15 (13.3) | 20 (35) | 19 (31.6) | 5 (80) | 2 (50) |
| Ciprofloxacin | 26 (7.7) | 6 (33.3) | 4 (25) | 7 (57.1) | 3 (100) | 1 (100) |
| Vancomycin | 46 (0) | 16 (6.3) | 21 (0) | 19 (0) | 6 (0) | 2 (0) |
| Oxacillin | 47 (74.5) | 15 (86.7) | 21 (100) | 19 (73.7) | — | — |
| Erythromycin | 47 (34) | 16 (62.5) | 21 (71.4) | 19 (36.8) | 5 (100) | 3 (33.3) |
| Clindamycin | 47 (25.5) | 15 (40) | 21 (28.6) | 19 (31.6) | 1 (100) | — |
| Linezolid | 21 (0) | 5 (0) | 4 (0) | 7 (0) | 3 (0) | 2 (50) |
| Tigecycline | 39 (2.6) | 14 (0) | 17 (17.6) | 19 (0) | 6 (16.7) | — |
| Co-trimoxazole | 26 (23.1) | 5 (40) | 4 (0) | 7 (28.6) | 1 (0) | — |
| Nitrofurantoin | 16 (0) | 3 (0) | 2 (0) | 6 (0) | 3 (0) | 1 (0) |
| Benzylpenicillin | 26 (96.2) | 6 (100) | 4 (100) | 7 (100) | 3 (66.7) | 1 (0) |
| Moxifloxacin | 25 (8) | 5 (0) | 4 (0) | 7 (28.6) | 1 (100) | — |
| Tetracycline | 25 (24) | 6 (33.3) | 4 (0) | 6 (33.3) | 3 (100) | 1 (100) |
| Chloramphenicol | 22 (4.5) | 12 (0) | 16 (18.8) | 14 (7.1) | 4 (0) | 3 (33.3) |
| Rifampin | 1 (0) | — | — | — | — | — |
| Quinupristin | 7 (0) | 2 (0) | 1 (0) | — | 1 (100) | — |
Data are represented in n (%); data were calculated based on 168 identified bacteria (in 9 cases more than one pathogen was found); CoNS, coagulase-negative Staphylococci; JUH, Jordan University Hospital.
Figure 2The treatment algorithm used in JUH for patients with postoperative orthopedic infection.